Sean D. Sullivan, BScPharm, MSc, PhD, is a Professor, University of Washington School of Pharmacy and Visiting Professor, London School of Economics and Political Science. His research interests include health technology assessment, medical decision-making, and economic evaluation of medical technology, including pharmaceuticals. Dr. Sullivan was a member of the Medicare Evidence Development and Coverage Advisory Committee, Chair of the Regence Blue Shield and Premera Blue Cross P/T Committee, and Chair of the Premera Blue Cross Value Assessment Committee. In 2020, he was elected to the National Academy of Medicine and in 2022 was elected Fellow, American Association for the Advancement of Science (AAAS). Recent Speaking Engagements Include: September 2025: US FDA Brown Bag Seminar – Implementation and Impact of the Medicare Drug Price Negotiation Program September 2025: London School of Economics, Market Access Academy – US Drug Pricing Policy, Most Favored Nations and Pharmaceutical Tariffs June 2025: ISPOR Health Policy Conference – Medicare Cost Savings from the First Round of Medicare Price Negotiations May 2025: ISPOR Annual Meeting – Including Part B Drugs in Medicare Price Negotiations May 2025: London School of Economics, Market Access Academy – US Drug Pricing Policy, Most Favored Nations and Pharmaceutical Tariffs